Stockscreener 앱 받기
38.46
0.44%
0.17
시장 영업 전:
38.20
-0.26
-0.68%
Vericel Corp 주식(VCEL)의 최신 뉴스
Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Vericel (VCEL) - The Globe and Mail
GW&K Investment Management LLC Acquires 290,795 Shares of Vericel Corporation $VCEL - MarketBeat
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026 - Yahoo Finance
Vericel (VCEL) CMO sells 4,375 shares after option exercise - Stock Titan
Vericel (NASDAQ:VCEL) Balances High Growth and Reasonable Valuation in Affordable Growth Screen - ChartMill
Proposed sale of 4,375 VCEL shares (NASDAQ: VCEL) - Stock Titan
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More - sharewise.com
VCEL Stock Price, Quote & Chart | VERICEL CORP (NASDAQ:VCEL) - ChartMill
Q1 2026 Vericel Corp Earnings Call Transcript - GuruFocus
Q3 2025 Vericel Corp Earnings Call Transcript - GuruFocus
Vericel (VCEL) amends bylaws to reflect new Burlington, MA global headquarters - Stock Titan
Vericel Corporation $VCEL Stock Position Reduced by Truist Financial Corp - MarketBeat
Vericel (VCEL) director McLaughlin exercises options and sells 7,000 shares - Stock Titan
Vericel CorporationCommon Stock (NQ: VCEL - FinancialContent
Vericel director Paul Wotton sells $327,425 in company stock By Investing.com - Investing.com Australia
Insider Sell: Paul Wotton Sells 10,000 Shares of Vericel Corp (V - GuruFocus
Vericel director Paul Wotton sells $327,425 in company stock - Investing.com
Director Paul K. Wotton sells 10,000 Vericel (VCEL) shares around $33 - Stock Titan
Issuer (NASDAQ: VCEL) notifies sale of 7,000 common shares - Stock Titan
Vericel (VCEL) Eps Diluted (TTM) - Zacks Investment Research
TradingKey - TradingKey
[144] Vericel Corp SEC Filing - Stock Titan
What is HC Wainwright's Estimate for Vericel Q4 Earnings? - MarketBeat
Analysts Have Made A Financial Statement On Vericel Corporation's (NASDAQ:VCEL) First-Quarter Report - Yahoo Finance
Vericel Corporation (NASDAQ:VCEL) Q1 2026 Earnings Call Transcript - Insider Monkey
Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth - ChartMill
Vericel Q1 Earnings Call Highlights - Yahoo Finance
Insider Sell: Mara Joseph Anthony Jr Sells 5,000 Shares of Veric - GuruFocus
Analysts Offer Insights on Healthcare Companies: Vericel (VCEL) and BridgeBio Pharma (BBIO) - The Globe and Mail
Vericel (VCEL) CFO 10b5-1 sale leaves 21,009 shares held - Stock Titan
Vericel (NASDAQ: VCEL) accounting chief sells 4,855 shares - Stock Titan
VCEL Maintains Buy Rating by HC Wainwright & Co. -- Price Target Raised to $64.00 - GuruFocus
Vericel Q1 2026 slides: 30% revenue growth drives guidance raise By Investing.com - Investing.com Australia
MSN Money - MSN
VCEL PE Ratio & Valuation, Is VCEL Overvalued - Intellectia AI
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance - Ortho Spine News
Vericel Q1 2026 slides: 30% revenue growth drives guidance raise - Investing.com
Earnings call transcript: Vericel’s Q1 2026 beats forecasts, stock surges - Investing.com
Earnings call transcript: Vericel’s Q1 2026 beats forecasts, stock surges By Investing.com - Investing.com South Africa
Jonathan Siegal files Form 144 — VCEL (NASDAQ: VCEL) sells 3,433 shares - Stock Titan
Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Vericel Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Vericel Corp 1Q 2026: Revenue $68.43M, EPS ($0.12) — 10-Q Summary - TradingView
BARDA burns contract backs NexoBrid growth at Vericel (VCEL) - Stock Titan
Vericel Corp (NASDAQ:VCEL) Smashes Q1 Estimates, Raises Full-Year Outlook as MACI and Burn Care Surge - ChartMill
VERICEL ($VCEL) Releases Q1 2026 Earnings - Quiver Quantitative
Vericel Reports Q1 2026: Revenue Up 30% to $68.4M, Adjusted EBITDA $9.6M - TradingView
Vericel (NASDAQ: VCEL) lifts 2026 outlook after 30% Q1 revenue gain - Stock Titan
Vericel Corporation Reports 30% Revenue Growth to $68.4 Million in Q1 2026, Raises Full-Year Guidance to $326-$336 Million - Quiver Quantitative
Burn care sales surge 91% as Vericel lifts 2026 revenue target - Stock Titan
VCEL (NASDAQ: VCEL) Form 144 lists 3,433 shares valued $130,454; vesting noted - Stock Titan
Vericel faces earnings test as Q1 loss looms after FDA approval - Investing.com Australia
1.27%
1.43%
자본화:
|
볼륨(24시간):